CHEMBIO DIAGNOSTICS, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 22 rows in 2017. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-12-28: Reporting owner Goldman Neil A; Form 3; Security Option to Purchase Common Stock; Transaction Holding.
- 2017-12-28: Reporting owner Goldman Neil A; Form 3; Security Option to Purchase Common Stock; Transaction Holding.
- 2017-12-28: Reporting owner Goldman Neil A; Form 3; Security Option to Purchase Common Stock; Transaction Holding.
- 2017-09-17: Reporting owner Klugewicz Sharon W; Form 4; Security Options (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-12-28 holding as of filing | Goldman Neil A Officer (Executive VP and CFO) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $7.04 exercise price | 2017-12-28 | ||
| 2017-12-28 holding as of filing | Goldman Neil A Officer (Executive VP and CFO) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $7.04 exercise price | 2017-12-28 | ||
| 2017-12-28 holding as of filing | Goldman Neil A Officer (Executive VP and CFO) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $7.04 exercise price | 2017-12-28 | ||
| 2017-09-17 | Klugewicz Sharon W Officer (President, Americas) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $5.90 | 2017-09-19 | |
| 2017-09-17 | Klugewicz Sharon W Officer (President, Americas) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $5.90 | 2017-09-19 | |
| 2017-08-28 | Klugewicz Sharon W Officer (President, Americas) | 4 | Options to purchase common stock Derivative · Direct | F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | −12,000 0 owned after | $4.45 exercise price | 2017-08-30 | |
| 2017-08-28 | Klugewicz Sharon W Officer (President, Americas) | 4 | Options to purchase common stock Derivative · Direct | F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | −12,000 0 owned after | $4.45 exercise price | 2017-08-30 | |
| 2017-08-28 | Klugewicz Sharon W Officer (President, Americas) | 4 | Options to purchase common stock Derivative · Direct | F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | −2,552 0 owned after | $4.45 exercise price | 2017-08-30 | |
| 2017-08-28 | Klugewicz Sharon W Officer (President, Americas) | 4 | Options to purchase common stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,448 0 owned after | $4.45 exercise price | 2017-08-30 | |
| 2017-07-13 | Meller Gary Director | 4 | Options to purchase common stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,375 0 owned after | $3.48 exercise price | 2017-07-17 | |
| 2017-07-13 | Meller Gary Director | 4 | Options to purchase common stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −625 8,750 owned after | $3.48 exercise price | 2017-07-17 | |
| 2017-07-04 | PAGE GAIL S Director | 4 | Option to Purchase Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,375 9,375 owned after | $6.05 | 2017-07-06 | |
| 2017-07-04 | PAGE GAIL S Director | 4 | Option to Purchase Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,375 9,375 owned after | $6.05 | 2017-07-06 | |
| 2017-07-04 | PAGE GAIL S Director | 4 | Options to Purchase Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,375 9,375 owned after | $6.05 | 2017-07-06 | |
| 2017-07-04 | PAGE GAIL S Director | 4 | Options to Purchase Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,375 9,375 owned after | $6.05 | 2017-07-06 | |
| 2017-07-04 | PAGE GAIL S Director | 4 | Options to Purchase Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,375 9,375 owned after | $6.05 | 2017-07-06 | |
| 2017-03-31 | Sperzel John J III Director, Officer (CEO / Director) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $5.37 | 2017-04-04 | |
| 2017-03-15 | Esfandiari Javan Officer (Chief Science Technol. Officer) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $5.25 | 2017-03-17 | |
| 2017-03-15 | Klugewicz Sharon W Officer (President, Americas) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $5.25 | 2017-03-17 | |
| 2017-03-15 | Larkin Richard J Officer (CFO) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $5.25 | 2017-03-17 | |
| 2017-03-15 | Sperzel John J III Officer (CEO) | 4 | Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $5.25 | 2017-03-17 | |
| 2017-02-14 | Esfandiari Javan Officer (Chief Science/Tech Officer) | 4 | Options to purchase common stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +7,969 0 owned after | $4.00 exercise price | 2017-03-16 |